Latest News and Press Releases

Delhi, April 27, 2023 (GLOBE NEWSWIRE) -- Tifcemalimab also known as TAB004 and JS004 is the world’s first in human recombinant humanized anti- BTLA (B and T lymphocyte attenuator) monoclonal...

Delhi, April 27, 2023 (GLOBE NEWSWIRE) -- Global Dopamine Cell Replacement Therapy Clinical Trials, Companies & Market Trends Insight 2023 Report Highlights: Research MethodologyGlobal Market...

Delhi, April 24, 2023 (GLOBE NEWSWIRE) -- Immune checkpoints play an important role in the regulation of the immune response against antigens under normal conditions. However, in cases when the...

Delhi, April 14, 2023 (GLOBE NEWSWIRE) -- Global Galectin Inhibitors Market Trends & Clinical Trials Insight 2023 Report Highlights: Global Galectin Inhibitors Clinical Pipeline By Company,...

Delhi, March 22, 2023 (GLOBE NEWSWIRE) -- Global CD276 Antibody Clinical Trials & Market Sales Forecast 2028 Report Highlights: Global CD276 Antibody Market Opportunity Assessment: > US$...

Delhi, March 22, 2023 (GLOBE NEWSWIRE) -- Tetraspecific Antibodies Clinical Trials, Proprietary Technologies, Companies & Market Trends Insight 2023 Report Highlights: Global Tetraspecific...

Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- China has emerged as a dominant force in the field of tetraspecific antibodies, leading the way in clinical trials and showing promising results in the...

Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- China Cell Therapy Market Opportunity & Clinical Trials Insight 2028 Report Highlights: More Than 400 Cell Therapies Are In Clinical Trials In...

Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- Global LAG-3 Inhibitor Market, Drug Sales, Price & Clinical Trials Insight 2028 Report Highlights: • Global LAG-3 Inhibitor Drug Market Opportunity...

Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- Tumor infiltrating lymphocyte (TIL) therapy is an emerging field in cancer immunotherapy. As researchers all over the world are conducting clinical trials...